Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
2.

Cardiovascular risk assessment of Bulgarian urban population: cross-sectional study.

Dyakova M, Shipkovenska E, Dyakov P, Dimitrov P, Torbova S.

Croat Med J. 2008 Dec;49(6):783-91.

3.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

4.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
6.

Trandolapril in Cushing's disease: short-term trandolapril treatment in patients with Cushing's disease and essential hypertension.

Zacharieva S, Torbova S, Orbetzova M, Vergilova J, Nachev E, Wippermann M, Baurenski L, Angelova-Gateva P, Tzingilev D.

Methods Find Exp Clin Pharmacol. 1998 Jun;20(5):433-8.

PMID:
9701782
7.

Losartan in Cushing's syndrome.

Zacharieva S, Orbetzova M, Natchev E, Vergilova J, Andrewa M, Wipperrnann M, Torbova S, Tzingilev D, Angelova-Gateva P.

Methods Find Exp Clin Pharmacol. 1998 Mar;20(2):163-8.

PMID:
9604859
8.

Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.

Zacharieva S, Torbova S, Orbetzova M, Borissova AM, Andonova K, Sheitanova S.

Methods Find Exp Clin Pharmacol. 1996 Apr;18(3):205-9.

PMID:
8738072
9.

Determination of aortic distensibility and its variations in arterial hypertension.

Torbova S, Sheiretova E, Belov Y.

Cor Vasa. 1981;23(2):126-31.

PMID:
7249660
10.

Content of prostaglandins E and F in the blood plasma and kidneys in arterial hypertension (clinical-experimental study).

Petkov O, Sirakov L, Belov Y, Sirakova I, Kolarova R, Torbova S, Popova N.

Acta Physiol Pharmacol Bulg. 1981;7(4):49-57.

PMID:
6954833
11.

[Radioisotopic functional diagnosis in uncomplicated hypertension].

Sheĭretova E, Torbova S, Ivanov Zh.

Vutr Boles. 1980;19(6):50-5. Bulgarian.

PMID:
7010786
12.

[Electrocardiographic changes and hemodynamic comparisons in arterial hypertension].

Belov Iu, Torbova S, Sheĭretova E, Urumov G.

Vutr Boles. 1980;19(3):16-26. Bulgarian.

PMID:
6994354
13.

Analysis of the corrected and uncorrected leads in patients with arterial hypertension.

Belov J, Urumov G, Torbova S.

Adv Cardiol. 1977;19:263-5. No abstract available.

PMID:
138348
14.

[Several lipid indices in hypertension].

Ilinov P, Torbova S, Rankov D.

Vutr Boles. 1976 Dec;15(6):52-7. Bulgarian.

PMID:
1014626
15.

[Several "risk factors" in patients with ischemic heart disease and hypertension].

Ilinov P, Popnikolov S, Torbova S.

Vutr Boles. 1976;15(4):11-7. Bulgarian.

PMID:
1007233
16.

[Experience with the electrophoretic separation of lipoproteins on Celogel].

Ilinov P, Torbova S, Popnikolov S.

Vutr Boles. 1975;14(3):137-43. Bulgarian.

PMID:
1226717
17.

Supplemental Content

Loading ...
Support Center